PPI before versus after Endoscopy in Treatment of Non-Variceal Upper Gastrointestinal Bleeding and their Impact on 30-Days Clinical Outcome. | ||||
| Journal of the Medical Research Institute | ||||
| Article 1, Volume 45, Issue 3, September 2024, Page 1-6 PDF (795.3 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/jmalexu.2024.288704.1019 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Neveen Mostafa   1; Abeer Ahmed Ali 2
| ||||
| 1Associate professor, Department of Experimental and Clinical Internal Medicine. Medical Research Institute, Alexandria University, Egypt | ||||
| 2Associate professor, Department of Chemical Pathology, Medical Research Institute, Alexandria University. | ||||
| Abstract | ||||
| Abstract Background: Acute upper gastrointestinal bleeding is a widespread medical emergency that represents a challenge to healthcare workers. Despite the notable improvement in management choices, there is no difference in mortality rate. Attentive assessment and examination before determining a treatment plan is associated with fewer complications. Deficient management of patients with upper gastrointestinal bleeding may escalate the risk of re-bleeding and other complications. Moreover, the timing of pharmacological and/or endoscopic intervention may influence the patient's outcome and should be precisely assigned to lower the risk of mortality and morbidity. Aim: To compare the management of upper gastrointestinal bleeding with pharmachological treatment before and after endoscopic intervention on 30 days' incidence of re-bleeding. Method Fifty patients presenting with non-variceal upper gastrointestinal bleeding were either treated with proton pump inhibitors as the first line of management or went directly for upper Esophagogastroduodenoscopy to control the bleeding, the impact of either way of treatment on 30 days’ clinical outcome was evaluated. Results No difference in 30 days' outcome between the patients who received proton pump inhibitors first before upper Esophagogastroduodenoscopy and the patients who had their endoscopy done first. Conclusion Giving proton pump inhibitors before or after doing upper Esophagogastroduodenoscopy in patients with non-variceal upper gastrointestinal bleeding doesn’t change the incidence of re-bleeding, but early endoscopy is associated with better outcomes. Keywords: Non-variceal, gastrointestinal bleeding, proton pump inhibitors, endoscopy, re-bleeding. | ||||
| Keywords | ||||
| Keywords: Non-variceal; gastrointestinal bleeding; proton pump inhibitors; endoscopy; re-bleeding | ||||
|
Statistics Article View: 131 PDF Download: 188 |
||||
